Published by Iain Gilbert on 27th May 2020
(Sharecast News) - Shares in Sorrento Therapeutics were up ahead of the bell on Wednesday after analysts at James Securities said the firm was a safe bet to develop an "antibody cocktail" that could potentially prevent people from catching Covid-19.
URL: http://www.digitallook.com/dl/news/story/30716107/...